Colgate-Palmolive (CL) Reports In-Line Q4 EPS
Get Alerts CL Hot Sheet
Price: $89.29 +0.47%
Revenue Growth %: +4.0%
Financial Fact:
Earnings per common share, diluted (in dollars per share): 0.78
Today's EPS Names:
FRSB, DGICA, UXIN, More
Revenue Growth %: +4.0%
Financial Fact:
Earnings per common share, diluted (in dollars per share): 0.78
Today's EPS Names:
FRSB, DGICA, UXIN, More
Join SI Premium – FREE
Colgate-Palmolive (NYSE: CL) reported Q4 EPS of $0.79, in-line with the analyst estimate of $0.79. Revenue for the quarter came in at $4.4 billion versus the consensus estimate of $4.43 billion.
Full Year 2022 Guidance
Based on current spot rates:
- The Company expects net sales growth to be 1% to 4% including a low-single-digit negative impact from foreign exchange.
- The Company expects organic sales growth to be within its long-term targeted range of 3% to 5%.
- On a GAAP basis, the Company expects gross profit margin expansion, increased advertising investment and double-digit earnings-per-share growth.
- On a non-GAAP (Base Business) basis, the Company expects gross profit margin expansion, increased advertising investment and low to mid-single-digit earnings-per-share growth.
For earnings history and earnings-related data on Colgate-Palmolive (CL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Gilead Sciences (GILD) Misses Q1 EPS by 288c
- USCB Financial Holdings, Inc. (USCB) Tops Q1 EPS by 2c
- The First Of Long Island (FLIC) Misses Q1 EPS by 3c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!